Posts Tagged ‘ICPH’
Immunotherapy: Cancer Care Gets Customized
Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics. Tiffani A. DeMarco, MS, CGC, is a board-certified…
Read MoreInova Schar Cancer Institute Recruiting Patients for ASCO’s Groundbreaking TAPUR Clinical Trial
Trial Will Learn From Use of Approved Targeted Cancer Therapies Matched to Tumor Genomic Profile Falls Church, VA — Inova Schar Cancer Institute announced today it is recruiting patients for the American Society of Clinical Oncology’s (ASCO) first-ever clinical trial, the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. The trial will evaluate molecularly targeted…
Read MoreWant to get your genome sequenced? At Inova, you’ll soon be able to. Washington Business Journal
The Northern Virginia health giant’s new partnership will give consumers a glimpse into their DNA. Read more.
Read MoreInova Personalized Health Accelerator Launches New Entrepreneur Education Program
Health System Driving Innovation by Developing the Next Generation of Healthcare Technology Entrepreneurs Fairfax, VA – The Inova Personalized Health Accelerator (IPHA) announced today that it is launching a free educational program designed for first-time healthcare technology entrepreneurs. The program is designed to provide entrepreneurs with a comprehensive set of skills required to execute the commercialization…
Read MoreInova Center for Personalized Health Announces Forum on Policy and Ethics Issues in Precision Medicine on Sept. 8
Fairfax, VA – Inova Center for Personalized Health (ICPH) announced today it will host the first-ever Precision Medicine Policy and Ethics Conference on Sept. 8, 2017 at Inova Center for Personalized Health in Fairfax, Va. The conference is a forum for national and industry leaders to address the most pressing challenges in the clinical adoption…
Read MoreInova Personalized Health Accelerator Names Michael Thomas as Director
Med Tech Veteran to Invest and Build Early Stage Healthcare Ventures with Personalized Health Focus Fairfax, VA – The Inova Personalized Health Accelerator (IPHA) announced today that health and biosciences industry veteran Michael Thomas has been appointed Director of the Accelerator. Prior to joining Inova, Michael was founder and CEO of Appian Partners, an Annapolis life…
Read MoreInova’s precision medicine accelerator takes atypical approach, Crain’s Washington DC
If precision medicine is the future of healthcare, Inova Health System wants a leg up. Read more.
Read MoreInova accelerator seeks personalized-medicine startups (Virginia Business)
The Inova Personalized Health Accelerator (IPHA) is preparing to accept applications from early-stage startups focused on predicting, preventing and treating disease. Read more.
Read MoreJohn McCain’s cancer: What is glioblastoma?, WUSA 9
Senator John McCain announced he was diagnosed with a primary brain tumor known as a glioblastoma. Our own Dr. John Deeken from the Inova Center for Personalized Health specializes in treating brain cancer and spoke with WUSA 9 about a gliobastoma diagnosis and treatment options. Watch more.
Read MoreInova Health System inks $60 million proton therapy deal, Washington Business Journal
Yet another health system joins the cancer-fighting technology race Inova Health System plans to begin offering proton beam therapy at its Inova Schar Cancer Institute by 2020 after signing a $60 million contract for a proton system from Reston-based Ion Beam Applications S.A. Read more.
Read More